Low‐Dose Ponatinib Is A Good Option In Chronic Myeloid...

  • Main
  • 2020 / 06
  • Low‐Dose Ponatinib Is A Good Option In Chronic Myeloid...
American Journal of Hematology 2020 / 06

Low‐Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis

Iurlo, Alessandra, Cattaneo, Daniele, Malato, Alessandra, Accurso, Vincenzo, Annunziata, Mario, Gozzini, Antonella, Scortechini, Anna Rita, Bucelli, Cristina, Scalzulli, Emilia, Attolico, Imma, Maggi,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25908
Date:
June, 2020
File:
PDF, 958 KB
2020
Conversion to is in progress
Conversion to is failed